{
    "2014-01-07": [
        "Nomura initiates CELG with BUY and $236 target (bull case $285). Best Risk/Reward in Large-Cap Biotech. 3 upsides",
        "BUY APA 87.90, SELL CELG 164.61, SELL GMCR 79.69, BUY JNJ 94.29.",
        "Epizyme shares rocket up on news of $29M milestone awards",
        "Epizyme shares rocket up on news of $29M milestone awards"
    ]
}